Inger Johansson
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism 73
- Biochemistry top 0.2%
- Eicosanoids and Hypertension Pharmacology 7
- Oncology top 1%
- Drug Transport and Resistance Mechanisms 20
- Cancer Treatment and Pharmacology 11
- Hepatology top 2%
- Liver physiology and pathology 7
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 73
-
- Alcohol Consumption and Health Effects 11
-
- Metabolism and Genetic Disorders 10
-
- Analytical Chemistry and Chromatography 7
- Co-authors
- Magnus Ingelman‐SundbergLeif BertilssonFolke SjöqvistMarja‐Liisa DahlErik EliassonMikael OscarsonQun‐Ying YueTommy B. Andersson
- Cited by
- PharmacologyBiochemistryOncology
- Journals
- Biochemical and Biophysical Research Communications (11 papers)European Journal of Clinical Pharmacology (8 papers)Clinical Pharmacology & Therapeutics (7 papers)
- Partner nations
- SwedenNetherlandsItaly
In The Last Decade
Inger Johansson
128 papers receiving 7.6k citations
Peers
Comparison fields: 5 of 155
- Pharmacology 4.6k
- Biochemistry 892
- Oncology 2.1k
- Hepatology 389
- Pharmacology 696
Countries citing papers authored by Inger Johansson
This map shows the geographic impact of Inger Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Johansson more than expected).
Fields of papers citing papers by Inger Johansson
This network shows the impact of papers produced by Inger Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Johansson. The network helps show where Inger Johansson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Inger Johansson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2021 | 45 | |
| 4 | 2014 | 58 | |
| 5 | 2013 | 46 | |
| 6 | 2012 | 21 | |
| 7 | 2010 | 37 | |
| 8 | 2008 | 26 | |
| 9 | 2008 | 25 | |
| 10 | 2005 | 31 | |
| 11 | Levels and trends of organohalogen compounds in mussels from the Seine estuary in 1981 - 2003 | 2004 | 6 |
| 12 | 2004 | 43 | |
| 13 | 2002 | 90 | |
| 14 | 1999 | 143 | |
| 15 | 1996 | 97 | |
| 16 | 1994 | 370 | |
| 17 | 1993 | 199 | |
| 18 | 1993 | 21 | |
| 19 | 1992 | 2 | |
| 20 | 1992 | 33 |
About Inger Johansson
Inger Johansson is a scholar working on Pharmacology, Biochemistry, Clinical Biochemistry, Oncology and Hepatology, having authored 133 papers that have together received 7.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (73 papers), Drug Transport and Resistance Mechanisms (20 papers), Cancer Treatment and Pharmacology (11 papers), Alcohol Consumption and Health Effects (11 papers), Metabolism and Genetic Disorders (10 papers), Analytical Chemistry and Chromatography (7 papers), Liver physiology and pathology (7 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). The work is most often cited by research in Pharmacology (4.6k citations), Biochemistry (892 citations), Oncology (2.1k citations), Hepatology (389 citations) and Pharmacology (696 citations). Inger Johansson has collaborated with scholars based in Sweden, Netherlands and Italy. Frequent co-authors include Magnus Ingelman‐Sundberg, Leif Bertilsson, Folke Sjöqvist, Marja‐Liisa Dahl, Erik Eliasson, Mikael Oscarson, Qun‐Ying Yue, Tommy B. Andersson, Åsa Nordling and Irene Persson. Their work appears in journals such as Biochemical and Biophysical Research Communications, European Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Journal of Biological Chemistry and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.